A Study of JMT601 in Participants With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin Lymphoma
Clinical trial NCT06725524 · RECRUITING
Trial details
- NCT number
- NCT06725524
- Sponsor
- Shanghai JMT-Bio Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-12
- Primary completion
- 2025-12-31
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.